Skip to main content
Log in

Renal versus splenic maximum slope based perfusion CT modelling in patients with portal-hypertension

  • Computed Tomography
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Purpose

To assess liver perfusion-CT (P-CT) parameters derived from peak-splenic (PSE) versus peak-renal enhancement (PRE) maximum slope-based modelling in different levels of portal-venous hypertension (PVH).

Material and methods

Twenty-four patients (16 men; mean age 68 ± 10 years) who underwent dynamic P-CT for detection of hepatocellular carcinoma (HCC) were retrospectively divided into three groups: (1) without PVH (n = 8), (2) with PVH (n = 8), (3) with PVH and thrombosis (n = 8). Time to PSE and PRE and arterial liver perfusion (ALP), portal-venous liver perfusion (PLP) and hepatic perfusion-index (HPI) of the liver and HCC derived from PSE- versus PRE-based modelling were compared between the groups.

Results

Time to PSE was significantly longer in PVH groups 2 and 3 (P = 0.02), whereas PRE was similar in groups 1, 2 and 3 (P > 0.05). In group 1, liver and HCC perfusion parameters were similar for PSE- and PRE-based modelling (all P > 0.05), whereas significant differences were seen for PLP and HPI (liver only) in group 2 and ALP in group 3 (all P < 0.05).

Conclusion

PSE is delayed in patients with PVH, resulting in a miscalculation of PSE-based P-CT parameters. Maximum slope-based P-CT might be improved by replacing PSE with PRE-modelling, whereas the difference between PSE and PRE might serve as a non-invasive biomarker of PVH.

Key Points

Peak-splenic enhancement is decreased and delayed in patients with portal-venous hypertension

The maximum-slope method uses PSE to calculate arterial and portal-venous liver perfusion

Peak-renal enhancement (PRE) is insensitive to PVH and might improve perfusion modelling

The difference between PSE and PRE might serve as a non-invasive PVH biomarker

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Vollmar B, Siegmund S, Menger MD (1998) An intravital fluorescence microscopic study of hepatic microvascular and cellular derangements in developing cirrhosis in rats. Hepatology 27:1544–1553

    Article  CAS  PubMed  Google Scholar 

  2. Richter S, Mucke I, Menger MD, Vollmar B (2000) Impact of intrinsic blood flow regulation in cirrhosis: maintenance of hepatic arterial buffer response. Am J Physiol Gastrointest Liver Physiol 279:G454–G462

    CAS  PubMed  Google Scholar 

  3. Gulberg V, Haag K, Rossle M, Gerbes AL (2002) Hepatic arterial buffer response in patients with advanced cirrhosis. Hepatology 35:630–634

    Article  PubMed  Google Scholar 

  4. Muto J, Shirabe K, Sugimachi K, Maehara Y (2014) Review of angiogenesis in hepatocellular carcinoma. Hepatol Res. doi:10.1111/hepr.12310

    PubMed  Google Scholar 

  5. Fischer MA, Kartalis N, Grigoriadis A et al (2015) Perfusion computed tomography for detection of hepatocellular carcinoma in patients with liver cirrhosis. Eur Radiol. doi:10.1007/s00330-015-3732-1

    PubMed Central  Google Scholar 

  6. Fischer MA, Leidner B, Kartalis N et al (2014) Time-resolved computed tomography of the liver: retrospective, multi-phase image reconstruction derived from volumetric perfusion imaging. Eur Radiol 24:151–161

    Article  PubMed  Google Scholar 

  7. Frampas E, Lassau N, Zappa M, Vullierme MP, Koscielny S, Vilgrain V (2013) Advanced Hepatocellular Carcinoma: early evaluation of response to targeted therapy and prognostic value of Perfusion CT and Dynamic Contrast Enhanced-Ultrasound. Preliminary results. Eur J Radiol 82:e205–e211

    Article  PubMed  Google Scholar 

  8. Morsbach F, Pfammatter T, Reiner CS et al (2013) Computed tomographic perfusion imaging for the prediction of response and survival to transarterial radioembolization of liver metastases. Investig Radiol 48:787–794

    Article  Google Scholar 

  9. Ronot M, Asselah T, Paradis V et al (2010) Liver fibrosis in chronic hepatitis C virus infection: differentiating minimal from intermediate fibrosis with perfusion CT. Radiology 256:135–142

    Article  PubMed  Google Scholar 

  10. Pandharipande PV, Krinsky GA, Rusinek H, Lee VS (2005) Perfusion imaging of the liver: current challenges and future goals. Radiology 234:661–673

    Article  PubMed  Google Scholar 

  11. Miles KA, Hayball MP, Dixon AK (1993) Functional images of hepatic perfusion obtained with dynamic CT. Radiology 188:405–411

    Article  CAS  PubMed  Google Scholar 

  12. Materne R, Van Beers BE, Smith AM et al (2000) Non-invasive quantification of liver perfusion with dynamic computed tomography and a dual-input one-compartmental model. Clin Sci (Lond) 99:517–525

    Article  CAS  Google Scholar 

  13. Cuenod C, Leconte I, Siauve N et al (2001) Early changes in liver perfusion caused by occult metastases in rats: detection with quantitative CT. Radiology 218:556–561

    Article  CAS  PubMed  Google Scholar 

  14. Blomley MJ, Coulden R, Dawson P et al (1995) Liver perfusion studied with ultrafast CT. J Comput Assist Tomogr 19:424–433

    Article  CAS  PubMed  Google Scholar 

  15. Tsushima Y, Funabasama S, Aoki J, Sanada S, Endo K (2004) Quantitative perfusion map of malignant liver tumors, created from dynamic computed tomography data. Acad Radiol 11:215–223

    Article  PubMed  Google Scholar 

  16. Awaya H, Mitchell DG, Kamishima T, Holland G, Ito K, Matsumoto T (2002) Cirrhosis: modified caudate-right lobe ratio. Radiology 224:769–774

    Article  PubMed  Google Scholar 

  17. Soresi M, Giannitrapani L, Cervello M, Licata A, Montalto G (2014) Non invasive tools for the diagnosis of liver cirrhosis. World J Gastroenterol 20:18131–18150

    Article  PubMed  PubMed Central  Google Scholar 

  18. European Association For The Study Of The Liver, European Organisation For Research and Treatment of Cancer (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56:908–943

    Article  Google Scholar 

  19. Bruix J, Sherman M, American Association for the Study of Liver D (2011) Management of hepatocellular carcinoma: an update. Hepatology 53:1020–1022

    Article  PubMed  PubMed Central  Google Scholar 

  20. Goetti R, Leschka S, Desbiolles L et al (2010) Quantitative computed tomography liver perfusion imaging using dynamic spiral scanning with variable pitch: feasibility and initial results in patients with cancer metastases. Investig Radiol 45:419–426

    Google Scholar 

  21. Weidekamm C, Cejna M, Kramer L, Peck-Radosavljevic M, Bader TR (2005) Effects of TIPS on liver perfusion measured by dynamic CT. AJR Am J Roentgenol 184:505–510

    Article  PubMed  Google Scholar 

  22. Kawanaka H, Akahoshi T, Kinjo N et al (2014) Effect of laparoscopic splenectomy on portal haemodynamics in patients with liver cirrhosis and portal hypertension. Br J Surg 101:1585–1593

    Article  CAS  PubMed  Google Scholar 

  23. Tsushima Y, Koizumi J, Yokoyama H, Takeda A, Kusano S (1998) Evaluation of portal pressure by splenic perfusion measurement using dynamic CT. AJR Am J Roentgenol 170:153–155

    Article  CAS  PubMed  Google Scholar 

  24. Ippolito D, Capraro C, Casiraghi A, Cestari C, Sironi S (2012) Quantitative assessment of tumour associated neovascularisation in patients with liver cirrhosis and hepatocellular carcinoma: role of dynamic-CT perfusion imaging. Eur Radiol 22:803–811

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The scientific guarantor of this publication is Prof. Peter Aspelin. The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article. The first author was financially supported by the Swiss Radiological Society. No other authors have received any funding. One of the authors has significant statistical expertise. Institutional Review Board approval was obtained. Written informed consent was waived by the Institutional Review Board.

In total 7/24 patients have been previously reported in Fischer MA, et al. Eur Radiol 24(1):151-61 and Fischer MA, et al. Eur Radiol 25(11): 3123-3132.

Methodology: retrospective, diagnostic study, performed at one institution.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michael A. Fischer.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fischer, M.A., Brehmer, K., Svensson, A. et al. Renal versus splenic maximum slope based perfusion CT modelling in patients with portal-hypertension. Eur Radiol 26, 4030–4036 (2016). https://doi.org/10.1007/s00330-016-4277-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-016-4277-7

Keywords

Navigation